专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP2482809B1 COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY BLEND 有权
公开(公告)号：EP2482809B1
公开(公告)日：2018-06-13
申请号：EP10762844.8
申请日：2010-10-01
申请人： Johnson & Johnson Consumer Inc.
发明人： KAUR, Simarna , SOUTHALL, Michael , TUCKER-SAMARAS, Samantha, D. , MAHMOOD, Khalid , SALIOU, Claude
IPC分类号： A61K36/756 , A61K36/815 , A61K36/88 , A61K36/9068 , A61K36/16 , A61K36/22 , A61K36/25 , A61K36/355 , A61K36/45 , A61K36/484 , A61K36/537 , A61K36/63 , A61K36/77 , A61K36/185 , A61K36/28 , A61K36/48
CPC分类号： A61K31/05 , A61K36/16 , A61K36/185 , A61K36/22 , A61K36/25 , A61K36/28 , A61K36/355 , A61K36/45 , A61K36/48 , A61K36/484 , A61K36/537 , A61K36/63 , A61K36/756 , A61K36/77 , A61K36/815 , A61K36/88 , A61K36/9068 , A61K45/06 , A61K2300/00
摘要： The present invention relates to a composition comprising an NF&kgr;B-inhibitor and an anti-inflammatory compound. The anti-inflammatory compound is not an NF&kgr;B-inhibitor and has an IC50 of about 70 μg/ml or less.

2. 发明公开

EP2895180A1 COMPOSITION FOR THE PREVENTION AND TREATMENT OF ACUTE AND RECURRENT URINARY TRACT INFECTIONS 有权
标题翻译：组成预防和治疗急性和复发性尿路感染
公开(公告)号：EP2895180A1
公开(公告)日：2015-07-22
申请号：EP12772733.7
申请日：2012-09-14
申请人： Claride Pharma S.A.
发明人： SFERRA, Daniela , RUSSO, Valentina , VERGALITO, Franca , FRANCESCHINI, Debora , MANGANO, Katia , SCAPAGNINI, Giovanni , DI MARCO, Roberto , LONGO, Sonia
IPC分类号： A61K36/185 , A61K36/29 , A61K36/756 , A61K36/59 , A61K36/53 , A61K36/718 , A61K36/66
CPC分类号： A61K36/29 , A61K36/185 , A61K36/53 , A61K36/59 , A61K36/66 , A61K36/718 , A61K36/756 , Y02A50/473
摘要： The present invention relates, in one aspect, to a composition or dietary supplement comprising a synergistic association of Arbutin and Berberine, optionally including an additional active ingredient of vegetal origin selected from Arbutin, Forskolin and mixtures thereof, for improving the health of the urinary tract and preventing or treating acute and recurrent urinary tract infections (UTI).

3. 发明授权

EP2362777B1 USE OF PHARMACEUTICAL COMPOSITIONS IN PREPARING PHARMACEUTICALS FOR TREATING DIABETIC ULCER 有权
标题翻译：的药用化合物药品生产用于糖尿病性溃疡治疗
公开(公告)号：EP2362777B1
公开(公告)日：2014-07-16
申请号：EP10809445.9
申请日：2010-01-20
申请人： Xu, Rongxiang
发明人： Xu, Rongxiang
IPC分类号： A61K36/75 , A61K36/718 , A61K36/66 , A61K36/481 , A61K36/185 , A61K35/64 , A61K9/06 , A61K9/107 , A61P17/02
CPC分类号： A61K36/75 , A61F13/00012 , A61F13/00063 , A61F13/00072 , A61F13/069 , A61F2013/00161 , A61F2013/0054 , A61F2013/0091 , A61F2013/00927 , A61K9/0014 , A61K9/06 , A61K35/62 , A61K35/644 , A61K36/185 , A61K36/539 , A61K36/66 , A61K36/71 , A61K36/718 , A61K36/756 , A61K47/44 , A61L15/34 , A61L15/40 , A61L15/44 , A61K2300/00
摘要： The use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer in limb or on body surface, or in preparing medical dressing. The pharmaceutical compositions consist of (A) 3 to 15% by weight of edible beeswax and (B) 85 to 97% by weight of sesame oil extract of Scutellaria root, Coptis root, Phellodendron bark, earthworm and poppy capsule, based on the total weight of the pharmaceutical compositions. In the sesame oil extract, each of Scutellaria root, Coptis root, Phellodendron bark, earthworm and poppy capsule is in an amount of 2 to 10% by weight of dry raw material based on the total weight of sesame oil. A medical dressing for treating diabetic ulcer and corresponding medicine box enclosing the said dressing are also provided.

4. 发明公开

EP2406763A2 TOPICAL COMPOSITIONS COMPRISING FERMENTED EXRACTS OF TRADITIONAL CHINESE MEDICINAL (TCM) INGREDIENTS, AND METHODS OF MAKING AND USING SAME 审中-公开
标题翻译：中药（TCM）和方法成分的发酵提取物：局部用组合物的生产和使用
公开(公告)号：EP2406763A2
公开(公告)日：2012-01-18
申请号：EP10751176.8
申请日：2010-03-01
申请人： ELC Management LLC
发明人： CHENG, Jing , CHEN, Chia , SCHNITTGER, Steven , MING, Lu
IPC分类号： G06Q50/00
CPC分类号： A61K36/725 , A61K8/97 , A61K8/99 , A61K36/06 , A61K36/068 , A61K36/074 , A61K36/076 , A61K36/10 , A61K36/16 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/236 , A61K36/258 , A61K36/28 , A61K36/41 , A61K36/535 , A61K36/539 , A61K36/65 , A61K36/69 , A61K36/704 , A61K36/752 , A61K36/756 , A61K36/804 , A61K36/8998 , A61K2800/85 , A61Q19/00
摘要： The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

5. 发明授权

EP1574218B1 A MEDICAMENT CONTAINING EPIMEDIUM EXTRACT FOR TREATMENT OF PROSTATIC HYPERPLASIA AND PROSTATITIS 有权
标题翻译：与淫羊藿药提取前列腺癌和前列腺炎的治疗
公开(公告)号：EP1574218B1
公开(公告)日：2010-07-28
申请号：EP03779644.8
申请日：2003-11-24
申请人： Bright Future Pharmaceutical Laboratories Limited
发明人： DONG, Hui
IPC分类号： A61P13/08 , A61K36/296
CPC分类号： A61K36/296 , A61K36/00 , A61K36/258 , A61K36/481 , A61K36/756 , A61K2300/00
摘要： The invention discloses a medicament for treatment of prostatic hyperplasia and prostatitis. The medicament contains flavonoid and polyose extracted from Epimedium plants in weight ratio 2-8:8-2, in which flavonoid from Epimedium contains 20-90% flavone and the molecule weight of polyose is 1000-700000 Dol. It also may add extracts from dried roots of Panax ginseng, pollen, dried roots of Astragalus membranaceus or A. Membranaceus mongholicus, dried roots of Phellodendron chinese or P Amurense as active ingredients. It has no side effect.

6. 发明公开

EP1574218A4 A MEDICAMENT CONTAINING EPIDEMIUM EXTRACT FOR TREATMENT OF PROSTATIC HYPERPLASIA AND PROSTATITIS 有权
标题翻译：与Epidemium药提取前列腺癌和前列腺炎的治疗
公开(公告)号：EP1574218A4
公开(公告)日：2007-06-06
申请号：EP03779644
申请日：2003-11-24
申请人： BRIGHT FUTURE PHARMACEUTICAL L
发明人： DONG HUI
IPC分类号： A61K31/715 , A61K36/00 , A61K36/258 , A61K36/296 , A61K36/481 , A61K36/756 , A61P13/08 , A61K35/78
CPC分类号： A61K36/296 , A61K36/00 , A61K36/258 , A61K36/481 , A61K36/756 , A61K2300/00
摘要： This present invention relates to a method for extracting Epimedium herb to prepare flavones and polysaccharides combinations in which their ratios vary from 2:8 to 8:2 by weight and applying these extracted compositions in treatment of prostatic hyperplasia. Total flavones of the extracts are in the range of 20-90% and the molecular weights of extracted polysaccharides vary from 1,000 to 700,000 Daltons. This invention also includes a method for preparing compounded formulations which contain extracts of Radix Ginseng, pollens, Radix Astragali, Cortex Phellodendri, Epimedium flavones and polysaccharides and administering these compositions directed at treatment of prostatic hyperplasia and prostatitis. Clinical study has showed that these extracts and formulations are effective in treatment of prostate illness with no adverse reactions.

7. 发明公开

EP1574218A1 A MEDICAMENT CONTAINING EPIDEMIUM EXTRACT FOR TREATMENT OF PROSTATIC HYPERPLASIA AND PROSTATITIS 有权
标题翻译： MEDIKAMENT MIT EPIMEDIUM-EXTRAKT ZUR BEHANDLUNG VON PROSTATAHYPERPLASIE UND PROSTATITIS
公开(公告)号：EP1574218A1
公开(公告)日：2005-09-14
申请号：EP03779644.8
申请日：2003-11-24
申请人： Bright Future Pharmaceutical Laboratories Limited
发明人： DONG, Hui
IPC分类号： A61K35/78 , A61P13/08
CPC分类号： A61K36/296 , A61K36/00 , A61K36/258 , A61K36/481 , A61K36/756 , A61K2300/00
摘要： This present invention relates to a method for extracting Epimedium herb to prepare flavones and polysaccharides combinations in which their ratios vary from 2:8 to 8:2 by weight and applying these extracted compositions in treatment of prostatic hyperplasia. Total flavones of the extracts are in the range of 20-90% and the molecular weights of extracted polysaccharides vary from 1,000 to 700,000 Daltons. This invention also includes a method for preparing compounded formulations which contain extracts of Radix Ginseng, pollens, Radix Astragali, Cortex Phellodendri, Epimedium flavones and polysaccharides and administering these compositions directed at treatment of prostatic hyperplasia and prostatitis. Clinical study has showed that these extracts and formulations are effective in treatment of prostate illness with no adverse reactions.
摘要翻译：本发明涉及一种用于提取淫羊藿草本以制备黄酮和多糖组合的方法，其中它们的比例为2:8至8:2重量比，并将这些提取的组合物应用于前列腺增生症的治疗。提取物的总黄酮在20-90％的范围内，提取的多糖的分子量在1,000至700,000道尔顿之间变化。本发明还包括制备含有人参，花粉，黄芪，皮质黄柏，淫羊藿黄酮和多糖的提取物的复方制剂的方法，并将这些组合物用于治疗前列腺增生和前列腺炎。临床研究表明，这些提取物和制剂对前列腺疾病的治疗是有效的，没有不良反应。

8. 发明公开

EP1495763A1 THERAPEUTIC CREAM FOR DERMATITIS 有权
标题翻译：治疗创伤发作
公开(公告)号：EP1495763A1
公开(公告)日：2005-01-12
申请号：EP02718592.5
申请日：2002-04-15
申请人： Santo, Tetsuo
发明人： SANTO, Tetsuo , LI, Songhua , WANG, Ruwei , IWASAKI, Sumio
IPC分类号： A61K35/78 , A61K31/10 , A61K31/16 , A61K7/00 , A61K7/48 , A61P17/00 , A61P7/00
CPC分类号： A61Q19/00 , A61K8/97 , A61K31/10 , A61K31/16 , A61K31/60 , A61K36/185 , A61K36/232 , A61K36/234 , A61K36/315 , A61K36/484 , A61K36/489 , A61K36/539 , A61K36/575 , A61K36/65 , A61K36/704 , A61K36/752 , A61K36/756 , A61K36/9066 , A61K2300/00
摘要： TECHNICAL FIELD: Cream for therapy of dermatitis TECHNICAL PROBLEM: To provide a cream for therapy effective against atopic dermatitis.
MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis
Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn. f.), 1%; Baikal Skullcap, 2%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; mutton oil, 3%; alcohol, 3%; and white soft paraffin, 70.5%.
An innovative therapy of various dermatitis such as atopic dermatitis can be attained by antibacterial, antiviral, antiallergic, antiphlogistic, blood-circulation accelerating, antifungal, sterilizing, anti-itching actions by the above respective ingredients, accelerating action for permeation of pharmacologically active ingredients to deep region of skin by Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization in the diseased part by salicylic acid and resorcinol.
Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.
摘要翻译：技术领域：用于治疗皮炎的霜技术问题：为治疗特应性皮炎提供治疗霜。解决方法：它有一个组成：Lightyellow Sophora Root，3％; 姜黄，2％; 木兰树皮2％; 木桐树皮2％; 叶子，1％; 婆罗洲樟树（Dryobalanops aromatica Gaertn。f。），1％; Baikal Skullcap，2％; 阿穆尔软木树，2％; 当归Dahuricae根，1％; 柠檬，3％ Smartweed，2％; 甘草，0.5％; Cnidii Rhizoma，0.5％; 日本当归根，0.5％; 水杨酸，0.5％; 间苯二酚，0.5％; 羊油3％; 酒，3％; 和白色软石蜡，70.5％。各种皮炎如创伤性皮炎的创新疗法可以通过抗菌，抗病毒，抗过敏，消炎，血液循环加速，抗真菌，灭菌，上述各成分的抗瘙痒作用，加速渗透作用药理活性成分由Cnidii Rhizoma和日本当归根深入皮肤区域，通过水杨酸和间苯二酚加速患病部位的角质化作用。主要用途：用于治疗皮炎，特别是特应性皮炎。

9. 发明公开

EP1462110A4 A MEDICINE FOR TREATING WOMAN CLIMACTERIC SYNDROME AND PREPARATION METHOD THEREOF 审中-公开
标题翻译：药物对女性更年期综合征和方法的处理生产同样
公开(公告)号：EP1462110A4
公开(公告)日：2004-10-20
申请号：EP02782659
申请日：2002-12-04
申请人： EU YAN SANG HONG KONG LTD
发明人： CHAN HSIAOCHANG , GOU YULIN , ROWLANDS DEWI , CHUNG YIUWA
IPC分类号： A61K36/00 , A61K36/06 , A61K36/534 , A61K36/8968 , A61P15/12 , A61K35/78 , A61K35/84
CPC分类号： A61K36/896 , A61K36/076 , A61K36/232 , A61K36/233 , A61K36/236 , A61K36/258 , A61K36/28 , A61K36/284 , A61K36/296 , A61K36/481 , A61K36/484 , A61K36/534 , A61K36/638 , A61K36/65 , A61K36/756 , A61K36/804 , A61K36/8964 , A61K36/8968 , A61K2300/00
摘要： The present invention discloses a new medicine for treating woman climacteric syndrome, it is prepared by processing, steam cooking, drying, pulverizing raw material comprising radix of Panax ginseng C. A. Mey., radix of Angelica sinensis (Oliv.) Diels, radix of Astragalus membranaceus (Fisch.) Bge. or Astragalus mongholicus Bge. or Astragalus chrysopterus Bge. or Astragalus floridus Benth. or Astragalus tongolensis Ulbr. , radix of Ophiopogon japonicus(Thunb.)Ker-Gawl., fructus of Ligustrum lucidum Ait., rhizoma of Atractylodes macrocephala Koidz., radix of Paeonia lactiflora Pall., Poria cocos(Schw.)Wolf., cortex of Phellodendron chinense Schneid. or Phellodendron amurense Rupr., rhizoma of Ligusticum chuanxiong Hort., radix of Glycyrrhiza uralensis Fisch. or Glycyrrhiza inflata Batal. or Glycyrrhiza glabra L., radix of Bupleurum chinense DC. or Bupleurum scorzonerifolium Willd., steamed and dried rhizoma of Rehmannia glutinosa (Gaertn.) Libosch. or Rehmannia glutinosa Libosch. f. hueichingcusis(Chao et Schih)Hsiao, herba of Epimedium brevicornum Maxim. or Epimedium sagittatum(Sieb. et Zucc.)Maxim. or Epimedium grandiflorum Morn, herba of Mentha haplocalyx Briq. or Mentha haplocalyx Briq. var. Pipcrascens (Malinvaud) C. Y. Wu et H. W. Li, rhizoma of Curculigo orchioides Gaertn., rhizoma of Anemarrhena asphodeloides Bge., herba of Eclipta prostrata L., and adding certain amount of water and honey to the raw materials powder, whereby forming water-honey-paste pill.

10. 发明公开

EP0606786A2 A pharmaceutical composition for treating thermal injuries of warm blooded mammals and human 失效
标题翻译：用于治疗温血动物和人的热损伤的药物组合物。
公开(公告)号：EP0606786A2
公开(公告)日：1994-07-20
申请号：EP93402890.3
申请日：1993-11-30
申请人： Xu, Rongxiang
发明人： Xu, Rongxiang
IPC分类号： A61K35/78 , A61K35/56
CPC分类号： A61K36/185 , A61K36/539 , A61K36/66 , A61K36/718 , A61K36/756 , A61K2300/00
摘要： This invention relates to a pharmaceutical composition mainly used for treating thermal injuries of warm blooded mammals and human. It is composed of 3 to 15% by weight of beeswax and 85 to 97% by weight of sesame oil extract of Huangqin, Huanglian, Huangbai, earthworm and poppy capsule. In the sesame oil extract, each of Huangqin, Huanglian, Huangbai, earthworm and poppy capsule is in an amount of 2 to 10 weight percent based upon the total weight of sesame oil. This invention also relates to a process for preparing the pharmaceutical composition.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式